A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)
Martha E. Teke, Amber Leila Sarvestani, Jonathan M. Hernandez, Hiran C. Fernando, Robert Timmerman
Topics & Concepts
SABR volatility modelMedicineAblative caseSurgical oncologyRadiologyStage (stratigraphy)Radiation therapyRadiosurgerynon-small cell lung cancer (NSCLC)Lung cancerStereotactic radiotherapyOncologyFinancial economicsA549 cellEconomicsPaleontologyVolatility (finance)Stochastic volatilityBiologyLung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsAdvanced Radiotherapy Techniques